1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Liver Model Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Liver Model Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liver Organoids
1.4.3 Liver-on-a-chip
1.4.4 2D Models
1.4.5 3D Bioprinting
1.4.6 Others
1.5 Market by Application
1.5.1 Global Human Liver Model Market Share by Application: 2021-2026
1.5.2 Drug Discovery
1.5.3 Education
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Liver Model Market
1.8.1 Global Human Liver Model Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Liver Model Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Human Liver Model Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Human Liver Model Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Liver Model Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Liver Model Sales Volume Market Share by Region (2015-2020)
3.2 Global Human Liver Model Sales Revenue Market Share by Region (2015-2020)
3.3 North America Human Liver Model Sales Volume
3.3.1 North America Human Liver Model Sales Volume Growth Rate (2015-2020)
3.3.2 North America Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Human Liver Model Sales Volume
3.4.1 East Asia Human Liver Model Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Human Liver Model Sales Volume (2015-2020)
3.5.1 Europe Human Liver Model Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Human Liver Model Sales Volume (2015-2020)
3.6.1 South Asia Human Liver Model Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Human Liver Model Sales Volume (2015-2020)
3.7.1 Southeast Asia Human Liver Model Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Human Liver Model Sales Volume (2015-2020)
3.8.1 Middle East Human Liver Model Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Human Liver Model Sales Volume (2015-2020)
3.9.1 Africa Human Liver Model Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Human Liver Model Sales Volume (2015-2020)
3.10.1 Oceania Human Liver Model Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Human Liver Model Sales Volume (2015-2020)
3.11.1 South America Human Liver Model Sales Volume Growth Rate (2015-2020)
3.11.2 South America Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Human Liver Model Sales Volume (2015-2020)
3.12.1 Rest of the World Human Liver Model Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Human Liver Model Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Human Liver Model Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Liver Model Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Liver Model Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Liver Model Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Liver Model Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Liver Model Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Liver Model Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Liver Model Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Liver Model Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Liver Model Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Liver Model Sales Volume Market Share by Type (2015-2020)
14.2 Global Human Liver Model Sales Revenue Market Share by Type (2015-2020)
14.3 Global Human Liver Model Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Human Liver Model Consumption Volume by Application (2015-2020)
15.2 Global Human Liver Model Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Human Liver Model Business
16.1 Emulate (US)
16.1.1 Emulate (US) Company Profile
16.1.2 Emulate (US) Human Liver Model Product Specification
16.1.3 Emulate (US) Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 CN Bio (UK)
16.2.1 CN Bio (UK) Company Profile
16.2.2 CN Bio (UK) Human Liver Model Product Specification
16.2.3 CN Bio (UK) Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Ascendance Bio (US)
16.3.1 Ascendance Bio (US) Company Profile
16.3.2 Ascendance Bio (US) Human Liver Model Product Specification
16.3.3 Ascendance Bio (US) Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Mimetas
16.4.1 Mimetas Company Profile
16.4.2 Mimetas Human Liver Model Product Specification
16.4.3 Mimetas Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 HIREL (US)
16.5.1 HIREL (US) Company Profile
16.5.2 HIREL (US) Human Liver Model Product Specification
16.5.3 HIREL (US) Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Cyfuse Biomedical (Japan)
16.6.1 Cyfuse Biomedical (Japan) Company Profile
16.6.2 Cyfuse Biomedical (Japan) Human Liver Model Product Specification
16.6.3 Cyfuse Biomedical (Japan) Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Organovo (US)
16.7.1 Organovo (US) Company Profile
16.7.2 Organovo (US) Human Liver Model Product Specification
16.7.3 Organovo (US) Human Liver Model Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Human Liver Model Manufacturing Cost Analysis
17.1 Human Liver Model Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Liver Model
17.4 Human Liver Model Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Liver Model Distributors List
18.3 Human Liver Model Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Liver Model (2021-2026)
20.2 Global Forecasted Revenue of Human Liver Model (2021-2026)
20.3 Global Forecasted Price of Human Liver Model (2015-2026)
20.4 Global Forecasted Production of Human Liver Model by Region (2021-2026)
20.4.1 North America Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.3 Europe Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.7 Africa Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.9 South America Human Liver Model Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Human Liver Model Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Human Liver Model by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Liver Model by Country
21.2 East Asia Market Forecasted Consumption of Human Liver Model by Country
21.3 Europe Market Forecasted Consumption of Human Liver Model by Countriy
21.4 South Asia Forecasted Consumption of Human Liver Model by Country
21.5 Southeast Asia Forecasted Consumption of Human Liver Model by Country
21.6 Middle East Forecasted Consumption of Human Liver Model by Country
21.7 Africa Forecasted Consumption of Human Liver Model by Country
21.8 Oceania Forecasted Consumption of Human Liver Model by Country
21.9 South America Forecasted Consumption of Human Liver Model by Country
21.10 Rest of the world Forecasted Consumption of Human Liver Model by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer